Use of methylphenidate in patients with cancer

Amit Sood, Debra L. Barton, Charles Lawrence Loprinzi

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Cancer and its treatment are often associated with symptoms such as depression, somnolence, cognitive abnormalities, and fatigue. Methylphenidate, a stimulant medication, is commonly used to treat these symptoms. Several small pilot and a few adequately powered studies have assessed the safety and efficacy of methylphenidate in patients with cancer. Overall, the studies so far suggest that methylphenidate is well-tolerated in patients with cancer. Further, the studies have provided initial evidence of efficacy of this agent in patients with cancer. The present article reviews the evidence base behind the use of methylphenidate in these patients.

Original languageEnglish (US)
Pages (from-to)35-40
Number of pages6
JournalAmerican Journal of Hospice and Palliative Medicine
Volume23
Issue number1
StatePublished - Jan 2006

Fingerprint

Methylphenidate
Neoplasms
Proxy
Fatigue
Safety
Therapeutics

Keywords

  • Cancer
  • Fatigue
  • Methylphenidate
  • Palliative care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Use of methylphenidate in patients with cancer. / Sood, Amit; Barton, Debra L.; Loprinzi, Charles Lawrence.

In: American Journal of Hospice and Palliative Medicine, Vol. 23, No. 1, 01.2006, p. 35-40.

Research output: Contribution to journalArticle

@article{72ae62ed123342c28d11d6c97e54d478,
title = "Use of methylphenidate in patients with cancer",
abstract = "Cancer and its treatment are often associated with symptoms such as depression, somnolence, cognitive abnormalities, and fatigue. Methylphenidate, a stimulant medication, is commonly used to treat these symptoms. Several small pilot and a few adequately powered studies have assessed the safety and efficacy of methylphenidate in patients with cancer. Overall, the studies so far suggest that methylphenidate is well-tolerated in patients with cancer. Further, the studies have provided initial evidence of efficacy of this agent in patients with cancer. The present article reviews the evidence base behind the use of methylphenidate in these patients.",
keywords = "Cancer, Fatigue, Methylphenidate, Palliative care",
author = "Amit Sood and Barton, {Debra L.} and Loprinzi, {Charles Lawrence}",
year = "2006",
month = "1",
language = "English (US)",
volume = "23",
pages = "35--40",
journal = "American Journal of Hospice and Palliative Medicine",
issn = "1049-9091",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Use of methylphenidate in patients with cancer

AU - Sood, Amit

AU - Barton, Debra L.

AU - Loprinzi, Charles Lawrence

PY - 2006/1

Y1 - 2006/1

N2 - Cancer and its treatment are often associated with symptoms such as depression, somnolence, cognitive abnormalities, and fatigue. Methylphenidate, a stimulant medication, is commonly used to treat these symptoms. Several small pilot and a few adequately powered studies have assessed the safety and efficacy of methylphenidate in patients with cancer. Overall, the studies so far suggest that methylphenidate is well-tolerated in patients with cancer. Further, the studies have provided initial evidence of efficacy of this agent in patients with cancer. The present article reviews the evidence base behind the use of methylphenidate in these patients.

AB - Cancer and its treatment are often associated with symptoms such as depression, somnolence, cognitive abnormalities, and fatigue. Methylphenidate, a stimulant medication, is commonly used to treat these symptoms. Several small pilot and a few adequately powered studies have assessed the safety and efficacy of methylphenidate in patients with cancer. Overall, the studies so far suggest that methylphenidate is well-tolerated in patients with cancer. Further, the studies have provided initial evidence of efficacy of this agent in patients with cancer. The present article reviews the evidence base behind the use of methylphenidate in these patients.

KW - Cancer

KW - Fatigue

KW - Methylphenidate

KW - Palliative care

UR - http://www.scopus.com/inward/record.url?scp=31644435912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31644435912&partnerID=8YFLogxK

M3 - Article

C2 - 16450661

AN - SCOPUS:31644435912

VL - 23

SP - 35

EP - 40

JO - American Journal of Hospice and Palliative Medicine

JF - American Journal of Hospice and Palliative Medicine

SN - 1049-9091

IS - 1

ER -